Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | NDAQ | CME |
|---|---|---|
| Price | $91.70 | $266.40 |
| Change today | ▼ 0.34% | ▲ 1.69% |
| Market cap | $51.26B | $95.79B |
| Return, 3 months | – | +15.9% |
| Return, year to date | – | +0.9% |
| Return, 1 year | – | +4.1% |
| P/E (TTM) | 26.7 | 22.6 |
| P/B | 4.3 | 3.6 |
| P/E percentile vs own 5y | 45th | 12th |
| Dividend yield | 1.22% | 4.22% |
| Revenue growth (YoY, latest qtr) | +20.5% | +0.8% |
| Net profit growth (YoY) | +12.2% | +1.6% |
| Gross margin | 43.4% | 86.2% |
| Operating margin | 30.5% | 65.1% |
| Net margin | 22.5% | 63.0% |
| Return on equity | 16.5% | 15.7% |
| Analyst target vs. price | +22.8% | +4.6% |
| Analyst buy share | 92% | 40% |
| RSI (14) | – | 41 |
| 30-day volatility | – | 23.1% |
| Max drawdown, 1 year | – | -31.1% |
| Trend read | – | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
